Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Lucid Group: Digital Delivery in Lockdown

Standing still is the fastest way of moving backwards in today's world. That's why we've been moving forward and transforming at every step to make sure we can continue to...

Lucid Group Communications Limited

- PMLiVE

Biogen completes filing for highly-anticipated Alzheimer’s drug

FDA has 60 days to decide whether to accept filing for review

- PMLiVE

Novavax gets $1.6bn from US government for coronavirus vaccine

Latest company to join Operation Warp Speed

- PMLiVE

Multichannel engagement and the need for greater understanding of European markets

By Laurence Olding and Georgina James

- PMLiVE

ENGINE MHP scores Charitable Campaign of the Year Award at Communiqué 2020

Campaign for Alzheimer’s Research UK was the clear winner

- PMLiVE

Porterhouse Medical Group – proud to be part of the first virtual Communiqué Awards 2020

At Porterhouse, we are always proud to support the Communiqué Awards, a leading healthcare and medical communications event that recognises the excellent work done by our global industry to communicate developments...

Porterhouse Medical Group

- PMLiVE

Moderna clashes with US scientists over pivotal COVID-19 vaccine trials

Delays allegedly resulting from a lack of cooperation

- PMLiVE

GSK signs deal with Medicago for COVID-19 vaccine

Collaboration will utilise GSK’s pandemic adjuvant platform

- PMLiVE

A snapshot of… Exscientia

In this month’s issue of PME, we take a look at Exscientia and talk to CEO Andrew Hopkins about the company’s technologies and the obstacles it faces in the biotech...

Lucid Group scoop a win and a high commendation at Communiqué 2020

Due to the COVID-19 pandemic, this year’s Communiqué awards was a virtual ceremony, celebrating some of the most inspiring work and people in medical communications.Lucid Group were delighted to come...

Lucid Group Communications Limited

AstraZeneca AZ

EU gives AZ’s Lynparza green light for BRCA-mutated pancreatic cancer

PARP inhibitor now available for rare, life-threatening disease

Onyx Health Tackles Diabetes with New Client

Onyx Health have continued to grow as an agency during the COVID-19 downturn, expanding their business into the South East of England by winning a new Surrey based client.

Onyx Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links